Cardinal health says expects 2021 non-gaap eps in range of $5.25 to $5.65

Q4 non-gaap earnings per share $1.04 (not $5.45).q4 gaap earnings per share $2.23 (not loss per share $12.61).cardinal health reports fourth quarter and full year results for fiscal year 2020.q4 revenue $36.7 billion versus refinitiv ibes estimate of $36.67 billion.q4 earnings per share estimate $0.92 -- refinitiv ibes data.sees 2021 non-gaap earnings per share $5.25 - $5.65.sees 2021 capital expenditures $400 million - $450 million.cardinal health - 2021 non-gaap eps guidance assumes incremental net headwind related to covid-19 of similar yoy magnitude as fiscal 2020.cardinal health - expects adverse impact from deferral, cancellation of elective procedures, physician office visits to continue, primarily in h1 2021.cardinal health - expects eventual recovery of elective procedures & physician office visits to pre-covid-19 levels exiting fiscal 2021.cardinal health - anticipates higher costs related to procuring ppe products for customers during pandemic to be headwind in fiscal 2021.qtrly revenue for pharmaceutical segment was flat at $33.2 billion.cardinal health - estimates covid-19 had net negative impact to both gaap & non-gaap operating earnings of about $130 million in q4.fy2021 earnings per share view $5.54 -- refinitiv ibes data.
CAH Ratings Summary
CAH Quant Ranking